NEW YORK, Jan. 25, 2017 /PRNewswire/ -- Yet another study has found a possible link between the genital use of talcum powder and an increased risk of ovarian cancer. The research, which was published this month in the European Journal of Cancer Prevention, consisted of a meta-analysis of 24 previously published statistical analyses and several prospective studies involving more than 300,000 ovarian cancer patients. Overall, women who used talc had about a 20% increased risk for ovarian cancer compared to those who did not. The report's authors characterized the findings as "statistically significant". (Case No 1422-CC09012-01)
"The publication of this research comes as thousands of ovarian cancer victims and their families pursue talcum powder lawsuits against Johnson & Johnson. The findings only add to the growing body of evidence suggesting that the regular and repeated use of talc-based powders for feminine hygiene purposes may contribute to the development of the disease," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer following years of genital talc use.
Johnson & Johnson Talcum Powder Litigation
Johnson & Johnson is named a defendant in more than 2,000 talcum powder lawsuits pending in courts around the country. All were filed on behalf of women diagnosed with ovarian cancer following long-term use of Baby Powder or Shower-to-Shower for feminine hygiene purposes. Plaintiffs allege that since the 1970s, a growing number of studies have pointed to a link between genital talc use and an increased risk of ovarian cancer. They further assert that Johnson & Johnson has long been aware of this research, but placed profits before consumer safety by withholding information and warnings from the public.
One of the country's largest talcum powder litigations is now underway in Missouri's 22nd Circuit Court for St. Louis, where three trials were convened last year. All three juries delivered verdicts in favor of plaintiffs, ordering Johnson & Johnson to pay compensatory and punitive damage awards totaling $55 million, $72 million and $70 million. Jury selection for the litigation's fourth trial is scheduled to begin on January 30th.
In additional to the cases pending in Missouri, nearly 100 talcum powder lawsuits filed against Johnson & Johnson have been centralized in a federal multidistrict litigation now underway in the U.S. District Court, District of New Jersey. (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation – MDL No.2738)
An additional 224 cases are pending in a multicounty litigation established in New Jersey's Atlantic County Superior Court. (In Re: Talc-Based Powder Products – Case No. 300)
Women who were diagnosed with ovarian cancer following the long-term, regular use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/talcum-powder-lawsuit-news-new-study-suggests-genital-talc-use-increases-ovarian-cancer-risk-by-20-bernstein-liebhard-llp-reports-300396738.html
SOURCE Bernstein Liebhard LLP